Kirsty Young was diagnosed with fibromyalgia and rheumatoid arthritis back in 2018, and was forced to leave her role on ...

AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, ...

With a combination of early diagnosis, modern treatments, and lifestyle changes, women with arthritis can significantly ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary ...

ANB032 was well tolerated across all doses with no safety signals observedAD trial and all further investment in ANB032 will be discontinuedAnticipate top-line Phase 2b data in rheumatoid arthritis in ...

Scientists at Weill Cornell Medicine and the Burke Neurological Institute have developed a groundbreaking drug that may ...

Due to advancements spurred by AI/ML, the impact of digital health technology will grow. Data from the Department for Promotion of Industry and Internal Trade show that FDI in the medicines and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Request To Download Free Sample of This Strategic Report @- In addition, rise in patient awareness toward availability of various treatments for rheumatoid arthritis, increase in focus of ...

Rates of heart failure with preserved ejection fraction (HFpEF) were doubled in patients with rheumatoid arthritis (RA) ...

New targeted drug therapies for a range of long-term conditions are being introduced by Manx Care. The move is in line with recommendations from NICE - the National Institute for Health and Care ...

The new treatments, which target a specific element of the illness, have been made available for conditions include ...